R87.62 vs R87.811
R87.62 (Abnormal cytological findings in specimens from vagina) compared with R87.811 (Vaginal high risk human papillomavirus (HPV) DNA test positive), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).
Can these codes be reported together?
Yes, when both are documented. R87.62 carries an Excludes2 note covering R87.811: “vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)”
Excludes2 marks distinct conditions — both may be reported when both are documented.
Side by side
| R87.62Abnormal cytological findings in specimens from vagina | R87.811Vaginal high risk human papillomavirus (HPV) DNA test positive | |
|---|---|---|
| Billing status | Non-billable header | Billable |
| Classification | R00-R99 — Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified (R00-R99) | R00-R99 — Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified (R00-R99) |
| Definition | Abnormal cytological findings in specimens from vagina is a non-billable ICD-10-CM category code (R87.62). | Vaginal high risk human papillomavirus (HPV) DNA test positive is a billable ICD-10-CM diagnosis code (R87.811). |
| Includes | abnormal findings in secretion and smears from cervix uteri abnormal findings in secretion and smears from vagina abnormal findings in secretion and smears from vulva | abnormal findings in secretion and smears from cervix uteri abnormal findings in secretion and smears from vagina abnormal findings in secretion and smears from vulva |
| Use additional code | code to identify acquired absence of uterus and cervix, if applicable (Z90.71-) | — |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources